Silk Road Medical, Inc(NASDAQ:SILK) 
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products includes ENROUTE Transcarotid Neuroprotection System that is used to directly ...
Website: http://www.silkroadmedical.com
Founded: 2007
IPO Price: $17 (Apr 04, 2019)
Full Time Employees: 224
CEO: Erica J. Rogers
Sector: Healthcare
Industry: Medical Devices
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
| Unit: USD | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 51,242,000 | 48,484,000 | 47,270,000 | 44,435,000 | 45,298,000 | 40,131,000 | 40,071,000 | 37,374,000 | 33,173,000 | 28,021,000 | 28,265,000 | 24,701,000 | 26,456,000 | 22,053,000 | 21,134,000 | 20,067,000 | 15,094,000 | 18,933,000 | 18,633,000 | 17,026,000 | 14,928,000 | 12,766,000 |
yoy | 13.12% | 20.81% | 17.97% | 18.89% | 36.55% | 43.22% | 41.77% | 51.31% | 25.39% | 27.06% | 33.74% | 23.09% | 75.27% | 16.48% | 13.42% | 17.86% | 1.11% | 48.31% | ||||
qoq | 5.69% | 2.57% | 6.38% | -1.91% | 12.88% | 0.15% | 7.22% | 12.66% | 18.39% | -0.86% | 14.43% | -6.63% | 19.97% | 4.35% | 5.32% | 32.95% | -20.28% | 1.61% | 9.44% | 14.05% | 16.94% | |
cost of goods sold | 12,736,000 | 11,983,000 | 12,468,000 | 12,050,000 | 13,004,000 | 12,526,000 | 10,979,000 | 9,308,000 | 9,012,000 | 8,577,000 | 7,233,000 | 6,076,000 | 6,598,000 | 5,538,000 | 5,217,000 | 5,488,000 | 5,336,000 | 5,250,000 | 4,721,000 | 4,170,000 | 3,697,000 | 3,339,000 |
gross profit | 38,506,000 | 36,501,000 | 34,802,000 | 32,385,000 | 32,294,000 | 27,605,000 | 29,092,000 | 28,066,000 | 24,161,000 | 19,444,000 | 21,032,000 | 18,625,000 | 19,858,000 | 16,515,000 | 15,917,000 | 14,579,000 | 9,758,000 | 13,683,000 | 13,912,000 | 12,856,000 | 11,231,000 | 9,427,000 |
yoy | 19.24% | 32.23% | 19.63% | 15.39% | 33.66% | 41.97% | 38.32% | 50.69% | 21.67% | 17.74% | 32.14% | 27.75% | 103.50% | 20.70% | 14.41% | 13.40% | -13.12% | 45.15% | ||||
qoq | 5.49% | 4.88% | 7.46% | 0.28% | 16.99% | -5.11% | 3.66% | 16.16% | 24.26% | -7.55% | 12.92% | -6.21% | 20.24% | 3.76% | 9.18% | 49.41% | -28.69% | -1.65% | 8.21% | 14.47% | 19.14% | |
gross margin % | 75.15% | 75.28% | 73.62% | 72.88% | 71.29% | 68.79% | 72.60% | 75.09% | 72.83% | 69.39% | 74.41% | 75.40% | 75.06% | 74.89% | 75.31% | 72.65% | 64.65% | 72.27% | 74.66% | 75.51% | 75.23% | 73.84% |
operating expenses: | ||||||||||||||||||||||
research and development | 11,883,000 | 10,660,000 | 10,064,000 | 10,047,000 | 10,780,000 | 10,433,000 | 9,200,000 | 8,471,000 | 10,655,000 | 8,123,000 | 7,499,000 | 6,867,000 | 7,261,000 | 5,484,000 | 10,039,000 | 4,711,000 | 3,393,000 | 3,131,000 | 3,264,000 | 3,187,000 | 3,113,000 | 2,707,000 |
selling, general and administrative | 43,818,000 | 40,775,000 | 39,110,000 | 36,009,000 | 35,830,000 | 34,082,000 | 32,522,000 | 28,821,000 | 27,700,000 | 27,275,000 | 27,595,000 | 25,049,000 | 22,549,000 | 21,194,000 | 20,872,000 | 19,202,000 | 15,758,000 | 19,692,000 | 18,156,000 | 17,064,000 | 14,135,000 | 13,866,000 |
total operating expenses | 55,701,000 | 51,435,000 | 49,174,000 | 46,056,000 | 46,610,000 | 44,515,000 | 41,722,000 | 37,292,000 | 38,355,000 | 35,398,000 | 35,094,000 | 31,916,000 | 29,810,000 | 26,678,000 | 30,911,000 | 23,913,000 | 19,151,000 | 22,823,000 | 21,420,000 | 20,251,000 | 17,248,000 | 16,573,000 |
income from operations | -17,195,000 | -14,934,000 | -14,372,000 | -13,671,000 | -14,316,000 | -16,910,000 | -12,630,000 | -9,226,000 | -14,194,000 | -15,954,000 | -14,062,000 | -13,291,000 | -9,952,000 | -10,163,000 | -14,994,000 | -9,334,000 | -9,393,000 | -9,140,000 | -7,508,000 | -7,395,000 | -6,017,000 | -7,146,000 |
yoy | 20.11% | -11.69% | 13.79% | 48.18% | 0.86% | 5.99% | -10.18% | -30.58% | 42.62% | 56.98% | -6.22% | 42.39% | 5.95% | 11.19% | 99.71% | 26.22% | 56.11% | 27.90% | ||||
qoq | 15.14% | 3.91% | 5.13% | -4.51% | -15.34% | 33.89% | 36.90% | -35.00% | -11.03% | 13.45% | 5.80% | 33.55% | -2.08% | -32.22% | 60.64% | -0.63% | 2.77% | 21.74% | 1.53% | 22.90% | -15.80% | |
operating margin % | -33.56% | -30.80% | -30.40% | -30.77% | -31.60% | -42.14% | -31.52% | -24.69% | -42.79% | -56.94% | -49.75% | -53.81% | -37.62% | -46.08% | -70.95% | -46.51% | -62.23% | -48.28% | -40.29% | -43.43% | -40.31% | -55.98% |
interest income | 2,321,000 | 2,471,000 | 2,618,000 | 2,617,000 | 2,434,000 | 2,287,000 | 1,776,000 | 617,000 | 122,000 | 12,000 | 15,000 | 42,000 | 47,000 | 95,000 | 153,000 | 249,000 | 299,000 | 404,000 | 441,000 | 565,000 | 598,000 | 52,000 |
interest expense | -1,725,000 | -1,721,000 | -1,734,000 | -1,732,000 | -1,712,000 | -1,693,000 | -1,732,000 | -1,714,000 | -1,031,000 | -621,000 | -634,000 | -633,000 | -628,000 | -623,000 | -791,000 | -1,215,000 | -1,203,000 | -1,202,000 | -1,216,000 | -1,176,000 | -1,207,000 | -1,352,000 |
other income | -4,000 | 48,000 | 477,000 | -2,000 | 110,000 | -144,000 | -28,000 | 4,000 | -50,000 | -116,000 | -12,000 | -3,000 | -6,000 | -3,000 | -6,000 | -15,000 | -56,000 | -3,000 | -8,000 | -1,000 | -5,333,000 | -15,712,000 |
net income | -16,603,000 | -14,136,000 | -13,011,000 | -12,788,000 | -13,484,000 | -16,460,000 | -12,614,000 | -10,319,000 | -15,398,000 | -16,679,000 | -14,693,000 | -13,885,000 | -10,539,000 | -10,694,000 | -16,757,000 | -10,315,000 | -10,353,000 | -9,941,000 | ||||
yoy | 23.13% | -14.12% | 3.15% | 23.93% | -12.43% | -1.31% | -14.15% | -25.68% | 46.10% | 55.97% | -12.32% | 34.61% | 1.80% | 7.57% | ||||||||
qoq | 17.45% | 8.65% | 1.74% | -5.16% | -18.08% | 30.49% | 22.24% | -32.98% | -7.68% | 13.52% | 5.82% | 31.75% | -1.45% | -36.18% | 62.45% | -0.37% | 4.14% | |||||
net income margin % | -32.40% | -29.16% | -27.52% | -28.78% | -29.77% | -41.02% | -31.48% | -27.61% | -46.42% | -59.52% | -51.98% | -56.21% | -39.84% | -48.49% | -79.29% | -51.40% | -68.59% | -52.51% | 0% | 0% | 0% | 0% |
other comprehensive loss: | ||||||||||||||||||||||
unrealized loss on investments | -105,000 | |||||||||||||||||||||
other comprehensive income loss | -105,000 | |||||||||||||||||||||
comprehensive loss | -16,708,000 | -14,225,000 | ||||||||||||||||||||
net income per share | -0.42 | -0.36 | -0.34 | -0.33 | -0.35 | -0.43 | -0.33 | -0.29 | -0.44 | -0.48 | -0.42 | -0.4 | -0.31 | -0.31 | -0.5 | -0.31 | -0.32 | -0.32 | -0.1 | -0.26 | -0.42 | -20.12 |
weighted-average common shares used to compute net income per share, basic and diluted | 39,620,888 | 39,261,496 | 38,804,343 | 38,865,011 | 38,765,166 | 38,532,202 | 35,775,672 | 35,303,958 | 35,143,178 | 35,023,297 | 34,635,358 | 34,736,015 | 34,534,099 | 34,336,433 | 33,757,599 | 32,682,360 | 31,338,310 | 30,764,354 | 28,458,793 | 1,200,719 | ||
other comprehensive income: | ||||||||||||||||||||||
unrealized gain on investments | -89,000 | 356,000 | 47,000 | -9,500 | -2,000 | -3,000 | -33,000 | -113,000 | -164,000 | -126,000 | ||||||||||||
other comprehensive income | -89,000 | |||||||||||||||||||||
loss on debt extinguishment | -245,000 | |||||||||||||||||||||
other comprehensive loss | -29,500 | 47,000 | -414,000 | |||||||||||||||||||
net income and comprehensive loss | -10,712,500 | -12,741,000 | -13,898,000 | -16,211,000 | -12,589,000 | -10,508,000 | -15,400,000 | -16,679,000 | -14,694,000 | -13,887,000 | -10,542,000 | -10,727,000 | -7,614,500 | -10,479,000 | -10,479,000 | -9,501,000 | -11,031,000 | -8,007,000 | -11,959,000 | -24,158,000 | ||
change in unrealized loss on investments | -414,000 | |||||||||||||||||||||
change in unrealized gain on investments | 249,000 | 25,000 | -189,000 | -2,000 | ||||||||||||||||||
net change in other comprehensive loss | 249,000 | 25,000 | -189,000 | -2,000 | -1,000 | -2,000 | -3,000 | -33,000 | -113,000 | -164,000 | -126,000 | 440,000 | ||||||||||
unrealized gains on investments | 440,000 | |||||||||||||||||||||
net income and comprehensive loss attributable to non-controlling interest | ||||||||||||||||||||||
net income and comprehensive loss attributable to silk road medical, inc. common stockholders | -8,289,000 | -8,007,000 |
Balance Sheets:
Quarterly
Annual
| Unit: USD | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | ||||||||||||||||||||||
current assets: | ||||||||||||||||||||||
cash and cash equivalents | 22,639,000 | 22,629,000 | 20,210,000 | 29,188,000 | 28,400,000 | 50,427,000 | 55,358,000 | 51,306,000 | 87,637,000 | 93,602,000 | 110,231,000 | 105,642,000 | 101,849,000 | 94,575,000 | 69,466,000 | 62,468,000 | 73,442,000 | 27,552,000 | 39,181,000 | 112,277,000 | 118,247,000 | 15,509,000 |
short-term investments | 149,344,000 | 151,833,000 | 161,264,000 | 163,673,000 | 159,961,000 | 138,640,000 | 158,316,000 | 53,826,000 | 21,234,000 | 17,127,000 | 26,293,000 | 41,497,000 | 78,016,000 | 91,442,000 | 84,416,000 | 70,067,000 | 51,508,000 | |||||
accounts receivable | 26,252,000 | 27,203,000 | 23,573,000 | 21,779,000 | 21,525,000 | 19,956,000 | 18,007,000 | 17,019,000 | 15,779,000 | 13,876,000 | 11,832,000 | 10,976,000 | 11,747,000 | 11,106,000 | 9,070,000 | 9,398,000 | 7,753,000 | 8,670,000 | 8,601,000 | 6,932,000 | 5,417,000 | 4,096,000 |
inventories | 29,682,000 | 30,486,000 | 29,876,000 | 22,066,000 | 19,067,000 | 17,182,000 | 19,293,000 | 20,293,000 | 17,616,000 | 17,726,000 | 17,851,000 | 16,049,000 | 12,771,000 | 11,960,000 | 9,989,000 | 10,946,000 | 11,621,000 | 12,101,000 | 10,322,000 | 9,275,000 | 8,963,000 | 8,056,000 |
prepaid expenses and other current assets | 13,104,000 | 3,543,000 | 5,912,000 | 4,277,000 | 4,543,000 | 4,049,000 | 3,924,000 | 4,543,000 | 4,653,000 | 2,564,000 | 3,412,000 | 4,662,000 | 5,877,000 | 4,757,000 | 6,787,000 | 3,443,000 | 3,863,000 | 1,894,000 | 2,878,000 | 3,503,000 | 3,249,000 | 1,391,000 |
total current assets | 241,021,000 | 235,694,000 | 240,835,000 | 240,983,000 | 233,496,000 | 230,254,000 | 254,898,000 | 146,987,000 | 146,919,000 | 127,768,000 | 143,326,000 | 154,456,000 | 158,537,000 | 163,895,000 | 173,328,000 | 177,697,000 | 181,095,000 | 120,284,000 | 112,490,000 | 131,987,000 | 135,876,000 | 29,052,000 |
long-term investments | 14,178,000 | 2,027,000 | 9,456,000 | 4,348,000 | 13,884,000 | 15,285,000 | 18,224,000 | |||||||||||||||
property and equipment | 8,381,000 | 8,085,000 | 8,114,000 | 8,337,000 | 8,644,000 | 8,897,000 | 9,372,000 | 9,671,000 | 9,755,000 | 9,866,000 | 7,697,000 | 5,132,000 | 3,428,000 | 2,777,000 | 2,844,000 | 2,824,000 | 2,885,000 | 2,707,000 | 2,734,000 | 2,697,000 | 2,743,000 | 2,846,000 |
other non-current assets | 6,227,000 | 6,508,000 | 6,904,000 | 7,196,000 | 7,336,000 | 4,996,000 | 5,260,000 | 5,731,000 | 5,815,000 | 5,134,000 | 5,370,000 | 5,711,000 | 5,931,000 | 2,680,000 | 2,832,000 | 2,997,000 | 3,233,000 | 3,444,000 | 3,644,000 | 3,575,000 | 3,723,000 | 6,460,000 |
total assets | 269,807,000 | 252,314,000 | 265,309,000 | 260,864,000 | 263,360,000 | 259,587,000 | 269,685,000 | 162,544,000 | 162,721,000 | 143,000,000 | 156,625,000 | 165,531,000 | 168,206,000 | 169,662,000 | 179,314,000 | 183,828,000 | 187,523,000 | 126,745,000 | 137,402,000 | 138,569,000 | 142,652,000 | 38,668,000 |
liabilities and stockholders' equity | ||||||||||||||||||||||
current liabilities: | ||||||||||||||||||||||
accounts payable | 3,693,000 | 2,966,000 | 5,676,000 | 5,094,000 | 5,338,000 | 5,272,000 | 2,523,000 | 4,312,000 | 3,666,000 | 2,926,000 | 2,379,000 | 4,908,000 | 1,958,000 | 2,923,000 | 2,598,000 | 2,046,000 | 2,542,000 | 3,194,000 | 1,898,000 | 1,965,000 | 1,189,000 | 3,134,000 |
accrued liabilities | 27,879,000 | 18,371,000 | 24,607,000 | 18,928,000 | 18,759,000 | 15,598,000 | 21,965,000 | 19,621,000 | 17,575,000 | 16,744,000 | 19,802,000 | 16,011,000 | 14,705,000 | 13,291,000 | 16,957,000 | 13,008,000 | 9,142,000 | 11,125,000 | 15,034,000 | 10,476,000 | 8,299,000 | 7,658,000 |
total current liabilities | 31,572,000 | 21,337,000 | 30,283,000 | 24,022,000 | 24,097,000 | 20,870,000 | 24,488,000 | 23,933,000 | 21,241,000 | 29,499,000 | 26,086,000 | 20,919,000 | 16,663,000 | 16,214,000 | 19,555,000 | 15,054,000 | 11,684,000 | 14,319,000 | 16,932,000 | 12,441,000 | 9,488,000 | 10,792,000 |
long-term debt | 76,147,000 | 75,886,000 | 75,626,000 | 75,364,000 | 75,104,000 | 74,848,000 | 74,596,000 | 74,340,000 | 74,033,000 | 38,901,000 | 44,786,000 | 48,652,000 | 48,614,000 | 48,574,000 | 48,533,000 | 45,160,000 | 45,066,000 | 44,972,000 | 44,879,000 | 44,785,000 | 44,690,000 | 44,597,000 |
other liabilities | 7,404,000 | 7,806,000 | 8,249,000 | 8,336,000 | 8,654,000 | 6,256,000 | 6,726,000 | 7,073,000 | 7,418,000 | 6,893,000 | 6,513,000 | 7,781,000 | 6,791,000 | 3,720,000 | 3,726,000 | 3,876,000 | 3,693,000 | 3,497,000 | 3,700,000 | 3,900,000 | 4,097,000 | 4,285,000 |
total liabilities | 115,123,000 | 105,029,000 | 114,158,000 | 107,722,000 | 107,855,000 | 101,974,000 | 105,810,000 | 105,346,000 | 102,692,000 | 75,293,000 | 77,385,000 | 77,352,000 | 72,068,000 | 68,508,000 | 71,814,000 | 64,090,000 | 60,443,000 | 62,788,000 | 65,511,000 | 61,126,000 | 58,275,000 | 91,477,000 |
commitments and contingencies | ||||||||||||||||||||||
stockholders' equity: | ||||||||||||||||||||||
preferred stock, 0.001 par value | ||||||||||||||||||||||
shares authorized: 5,000,000 at june 30, 2024 and december 31, 2023 | ||||||||||||||||||||||
shares issued and outstanding: none at june 30, 2024 and december 31, 2023 | ||||||||||||||||||||||
common stock | ||||||||||||||||||||||
shares authorized: 100,000,000 at june 30, 2024 and december 31, 2023 | ||||||||||||||||||||||
shares issued and outstanding: 40,612,481 and 39,165,481 at june 30, 2024 and december 31, 2023, respectively | 41,000 | |||||||||||||||||||||
additional paid-in capital | 584,959,000 | 560,854,000 | 550,495,000 | 539,831,000 | 529,453,000 | 517,663,000 | 507,715,000 | 388,452,000 | 380,775,000 | 373,053,000 | 367,907,000 | 362,152,000 | 356,224,000 | 350,699,000 | 346,318,000 | 341,687,000 | 338,550,000 | 264,951,000 | 263,384,000 | 260,647,000 | 259,574,000 | 5,194,000 |
accumulated other comprehensive income | -122,000 | -17,000 | 72,000 | 83,000 | -166,000 | -191,000 | -2,000 | 1,000 | 3,000 | 6,000 | 39,000 | 152,000 | 316,000 | 442,000 | 2,000 | |||||||
accumulated deficit | -430,194,000 | -413,591,000 | -399,455,000 | -386,444,000 | -373,656,000 | -360,172,000 | -343,712,000 | -331,098,000 | -320,779,000 | -305,381,000 | -288,702,000 | -274,009,000 | -260,124,000 | -249,585,000 | -238,891,000 | -222,135,000 | -211,820,000 | -201,467,000 | -191,526,000 | -183,235,000 | -175,228,000 | -163,269,000 |
total stockholders' equity | 154,684,000 | 147,285,000 | 151,151,000 | 153,142,000 | 155,505,000 | 157,613,000 | 163,875,000 | 57,198,000 | 60,029,000 | 67,707,000 | 79,240,000 | 88,179,000 | 96,138,000 | 101,154,000 | 119,738,000 | 127,080,000 | 63,957,000 | 77,443,000 | 84,377,000 | |||
total liabilities and stockholders' equity | 269,807,000 | 252,314,000 | 265,309,000 | 260,864,000 | 263,360,000 | 259,587,000 | 269,685,000 | 162,544,000 | 162,721,000 | 143,000,000 | 156,625,000 | 165,531,000 | 168,206,000 | 169,662,000 | 183,828,000 | 187,523,000 | 126,745,000 | |||||
shares authorized: 5,000,000 at march 31, 2024 and december 31, 2023 | ||||||||||||||||||||||
shares issued and outstanding: none at march 31, 2024 and december 31, 2023 | ||||||||||||||||||||||
shares authorized: 100,000,000 at march 31, 2024 and december 31, 2023 | ||||||||||||||||||||||
shares issued and outstanding: 39,436,634 and 39,165,481 at march 31, 2024 and december 31, 2023, respectively | 39,000 | |||||||||||||||||||||
restricted cash | 155,000 | 155,000 | 155,000 | 232,000 | 232,000 | 232,000 | 232,000 | 310,000 | 310,000 | 310,000 | 310,000 | 310,000 | 310,000 | 310,000 | 310,000 | 310,000 | 310,000 | |||||
shares authorized: 5,000,000 at december 31, 2023 and 2022 | ||||||||||||||||||||||
shares issued and outstanding: none at december 31, 2023 and 2022 | ||||||||||||||||||||||
shares authorized: 100,000,000 at december 31, 2023 and 2022 | ||||||||||||||||||||||
shares issued and outstanding: 39,165,481 and 38,355,972 at december 31, 2023 and 2022, respectively | 39,000 | |||||||||||||||||||||
shares authorized: 5,000,000 at september 30, 2023 and december 31, 2022 | ||||||||||||||||||||||
shares issued and outstanding: none at september 30, 2023 and december 31, 2022 | ||||||||||||||||||||||
shares authorized: 100,000,000 at september 30, 2023 and december 31, 2022 | ||||||||||||||||||||||
shares issued and outstanding: 38,907,789 and 38,355,972 at september 30, 2023 and december 31, 2022, respectively | 39,000 | |||||||||||||||||||||
accumulated other comprehensive loss | -284,000 | -331,000 | ||||||||||||||||||||
shares authorized: 5,000,000 at june 30, 2023 and december 31, 2022 | ||||||||||||||||||||||
shares issued and outstanding: none at june 30, 2023 and december 31, 2022 | ||||||||||||||||||||||
shares authorized: 100,000,000 at june 30, 2023 and december 31, 2022 | ||||||||||||||||||||||
shares issued and outstanding: 38,812,280 and 38,355,972 at june 30, 2023 and december 31, 2022, respectively | 39,000 | |||||||||||||||||||||
shares authorized: 5,000,000 at march 31, 2023 and december 31, 2022 | ||||||||||||||||||||||
shares issued and outstanding: none at march 31, 2023 and december 31, 2022 | ||||||||||||||||||||||
shares authorized: 100,000,000 at march 31, 2023 and december 31, 2022 | ||||||||||||||||||||||
shares issued and outstanding: 38,708,441 and 38,355,972 at march 31, 2023 and december 31, 2022, respectively | 39,000 | |||||||||||||||||||||
short-term debt | 9,829,000 | 3,905,000 | ||||||||||||||||||||
shares authorized: 5,000,000 at december 31, 2022 and 2021 | ||||||||||||||||||||||
shares issued and outstanding: none at december 31, 2022 and 2021 | ||||||||||||||||||||||
shares authorized: 100,000,000 at december 31, 2022 and 2021 | ||||||||||||||||||||||
shares issued and outstanding: 38,355,972 and 34,980,896 at december 31, 2022 and 2021, respectively | 38,000 | |||||||||||||||||||||
shares authorized: 5,000,000 at september 30, 2022 and december 31, 2021 | ||||||||||||||||||||||
shares issued and outstanding: none at september 30, 2022 and december 31, 2021 | ||||||||||||||||||||||
shares authorized: 100,000,000 at september 30, 2022 and december 31, 2021 | ||||||||||||||||||||||
shares issued and outstanding: 35,381,085 and 34,980,896 at september 30, 2022 and december 31, 2021, respectively | 35,000 | |||||||||||||||||||||
shares authorized: 5,000,000 at june 30, 2022 and december 31, 2021 | ||||||||||||||||||||||
shares issued and outstanding: none at june 30, 2022 and december 31, 2021 | ||||||||||||||||||||||
shares authorized: 100,000,000 at june 30, 2022 and december 31, 2021 | ||||||||||||||||||||||
shares issued and outstanding: 35,193,169 and 34,980,896 at june 30, 2022 and december 31, 2021, respectively | 35,000 | |||||||||||||||||||||
shares authorized: 5,000,000 at march 31, 2022 and december 31, 2021 | ||||||||||||||||||||||
shares issued and outstanding: none at march 31, 2022 and december 31, 2021 | ||||||||||||||||||||||
shares authorized: 100,000,000 at march 31, 2022 and december 31, 2021 | ||||||||||||||||||||||
shares issued and outstanding: 35,073,602 and 34,980,896 at march 31, 2022 and december 31, 2021, respectively | 35,000 | |||||||||||||||||||||
shares authorized: 5,000,000 at december 31, 2021 and 2020 | ||||||||||||||||||||||
shares issued and outstanding: none at december 31, 2021 and 2020 | ||||||||||||||||||||||
shares authorized: 100,000,000 at december 31, 2021 and 2020 | ||||||||||||||||||||||
shares issued and outstanding: 34,980,896 and 34,249,649 at december 31, 2021 and 2020, respectively | 35,000 | |||||||||||||||||||||
shares authorized: 5,000,000 at september 30, 2021 and december 31, 2020 | ||||||||||||||||||||||
shares issued and outstanding: none at september 30, 2021 and december 31, 2020 | ||||||||||||||||||||||
shares authorized: 100,000,000 at september 30, 2021 and december 31, 2020 | ||||||||||||||||||||||
shares issued and outstanding: 34,854,822 and 34,249,649 at september 30, 2021 and december 31, 2020, respectively | 35,000 | |||||||||||||||||||||
shares authorized: 5,000,000 at june 30, 2021 and december 31, 2020 | ||||||||||||||||||||||
shares issued and outstanding: none at june 30, 2021 and december 31, 2020 | ||||||||||||||||||||||
shares authorized: 100,000,000 at june 30, 2021 and december 31, 2020 | ||||||||||||||||||||||
shares issued and outstanding: 34,623,409 and 34,249,649 at june 30, 2021 and december 31, 2020, respectively | 35,000 | |||||||||||||||||||||
shares authorized: 5,000,000 at march 31, 2021 and december 31, 2020 | ||||||||||||||||||||||
shares issued and outstanding: none at march 31, 2021 and december 31, 2020 | ||||||||||||||||||||||
shares authorized: 100,000,000 at march 31, 2021 and december 31, 2020 | ||||||||||||||||||||||
shares issued and outstanding: 34,438,290 and 34,249,649 at march 31, 2021 and december 31, 2020, respectively | 34,000 | |||||||||||||||||||||
liabilities and stockholders’ equity | ||||||||||||||||||||||
stockholders’ equity): | ||||||||||||||||||||||
shares authorized: 5,000,000 at december 31, 2020 and 2019 | ||||||||||||||||||||||
shares issued and outstanding: none at december 31, 2020 and 2019 | ||||||||||||||||||||||
shares authorized: 100,000,000 at december 31, 2020 and 2019 | ||||||||||||||||||||||
shares issued and outstanding: 34,249,649 and 31,255,267 at december 31, 2020 and 2019, respectively | 34,000 | |||||||||||||||||||||
total stockholders’ equity | 107,500,000 | 71,891,000 | ||||||||||||||||||||
total liabilities and stockholders’ equity | 179,314,000 | 137,402,000 | ||||||||||||||||||||
shares authorized: 5,000,000 at september 30, 2020 and december 31, 2019 | ||||||||||||||||||||||
shares issued and outstanding: none | ||||||||||||||||||||||
shares authorized: 100,000,000 at september 30, 2020 and december 31, 2019 | ||||||||||||||||||||||
shares issued and outstanding: 33,889,077 and 31,255,267 at september 30, 2020 and december 31, 2019, respectively | 34,000 | |||||||||||||||||||||
shares authorized: 5,000,000 at june 30, 2020 and december 31, 2019 | ||||||||||||||||||||||
shares authorized: 100,000,000 at june 30, 2020 and december 31, 2019 | ||||||||||||||||||||||
shares issued and outstanding: 33,610,099 and 31,255,267 at june 30, 2020 and december 31, 2019, respectively | 34,000 | |||||||||||||||||||||
shares authorized: 5,000,000 at march 31, 2020 and december 31, 2019 | ||||||||||||||||||||||
shares authorized: 100,000,000 at march 31, 2020 and december 31, 2019 | ||||||||||||||||||||||
shares issued and outstanding: 31,395,637 and 31,255,267 at march 31, 2020 and december 31, 2019, respectively | 31,000 | |||||||||||||||||||||
liabilities, redeemable convertible preferred stock and stockholders’ equity | ||||||||||||||||||||||
redeemable convertible preferred stock | 31,803,000 | |||||||||||||||||||||
shares authorized: none and 24,069,615 at december 31, 2019 and 2018, respectively | ||||||||||||||||||||||
shares issued and outstanding: none and 21,233,190 at december 31, 2019 and 2018, respectively | ||||||||||||||||||||||
liquidation preference: none and 121,144 at december 31, 2019 and 2018, respectively | ||||||||||||||||||||||
stockholders’ equity | ||||||||||||||||||||||
shares authorized: 5,000,000 and none at december 31, 2019 and 2018, respectively | ||||||||||||||||||||||
shares issued and outstanding: none at december 31, 2019 and 2018 | ||||||||||||||||||||||
shares authorized: 100,000,000 and 29,879,220 at december 31, 2019 and 2018, respectively | ||||||||||||||||||||||
shares issued and outstanding: 31,255,267 and 1,135,310 at december 31, 2019 and 2018, respectively | 31,000 | |||||||||||||||||||||
liabilities, redeemable convertible preferred stock and stockholders' equity | ||||||||||||||||||||||
shares authorized: none and 24,069,615 at september 30, 2019 and december 31, 2018, respectively | ||||||||||||||||||||||
shares issued and outstanding: none and 21,233,190 at september 30, 2019 and december 31, 2018, respectively | ||||||||||||||||||||||
liquidation preference: none and 121,144 at september 30, 2019 and december 31, 2018, respectively | ||||||||||||||||||||||
stockholders' equity | ||||||||||||||||||||||
shares authorized: 5,000,000 and none at september 30, 2019 and december 31, 2018, respectively | ||||||||||||||||||||||
shares authorized: 100,000,000 and 29,879,220 at september 30, 2019 and december 31, 2018, respectively | ||||||||||||||||||||||
shares issued and outstanding: 30,775,980 and 1,135,310 at september 30, 2019 and december 31, 2018, respectively | 31,000 | |||||||||||||||||||||
total liabilities, redeemable convertible preferred stock and stockholders' equity | 138,569,000 | 142,652,000 | ||||||||||||||||||||
shares authorized: none and 24,069,615 at june 30, 2019 and december 31, 2018, respectively | ||||||||||||||||||||||
shares issued and outstanding: none and 21,233,190 at june 30, 2019 and december 31, 2018, respectively | ||||||||||||||||||||||
liquidation preference: none and 121,144 at june 30, 2019 and december 31, 2018, respectively | ||||||||||||||||||||||
shares authorized: 5,000,000 and none at june 30, 2019 and december 31, 2018, respectively | ||||||||||||||||||||||
shares authorized: 100,000,000 and 29,879,220 at june 30, 2019 and december 31, 2018, respectively | ||||||||||||||||||||||
shares issued and outstanding: 30,747,714 and 1,135,310 at june 30, 2019 and december 31, 2018, respectively | 31,000 | |||||||||||||||||||||
liabilities, redeemable convertible preferred stock and stockholders' deficit | ||||||||||||||||||||||
shares authorized: 24,069,615 at march 31, 2019 and december 31, 2018 | ||||||||||||||||||||||
shares issued and outstanding: 21,238,105 and 21,233,190 at march 31, 2019 and december 31, 2018, respectively | ||||||||||||||||||||||
liquidation preference: 121,174 and 121,144 at march 31, 2019 and december 31, 2018, respectively | 105,265,000 | |||||||||||||||||||||
stockholders' deficit: | ||||||||||||||||||||||
shares authorized: 29,879,220 at march 31, 2019 and december 31, 2018 | ||||||||||||||||||||||
shares issued and outstanding: 1,386,615 and 1,135,310 at march 31, 2019 and december 31, 2018, respectively | 1,000 | |||||||||||||||||||||
total stockholders' deficit | -158,074,000 | |||||||||||||||||||||
total liabilities, redeemable convertible preferred stock and stockholders' deficit | 38,668,000 |
Cashflow Statements:
Quarterly
Annual
| Unit: USD | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities | ||||||||||||||||||||||
net income | -16,603,000 | -14,136,000 | -13,011,000 | -12,788,000 | -13,484,000 | -16,460,000 | -12,614,000 | -10,319,000 | -15,398,000 | -16,679,000 | -14,693,000 | -13,885,000 | -10,539,000 | -10,694,000 | -16,757,000 | -10,314,000 | -10,353,000 | -9,941,000 | -8,291,000 | -8,007,000 | -11,959,000 | -24,158,000 |
adjustments to reconcile net income to net cash from operating activities: | ||||||||||||||||||||||
depreciation and amortization expense | 665,000 | 644,000 | 656,000 | 656,000 | 685,000 | 699,000 | 662,000 | 543,000 | 502,000 | 420,000 | 309,000 | 241,000 | 243,000 | 239,000 | 226,000 | 195,000 | 184,000 | 184,000 | 182,000 | 180,000 | 176,000 | 174,000 |
stock-based compensation expense | 11,040,000 | 10,359,000 | 9,609,000 | 10,247,000 | 10,199,000 | 8,838,000 | 7,545,000 | 6,339,000 | 6,161,000 | 4,978,000 | 3,984,000 | 3,686,000 | 3,409,000 | 3,533,000 | 2,273,000 | 2,006,000 | 1,654,000 | 1,293,000 | 954,000 | 924,000 | 837,000 | 262,000 |
accretion of discounts on investments | -1,045,000 | -1,359,000 | -1,918,000 | |||||||||||||||||||
amortization of debt discount and debt issuance costs | 58,000 | 59,000 | 59,000 | 59,000 | 57,000 | 57,000 | 58,000 | 69,000 | 52,000 | 39,000 | 39,000 | 39,000 | 39,000 | 41,000 | 31,000 | 12,000 | 11,000 | 12,000 | 12,000 | 12,000 | 11,000 | 11,000 |
amortization of right-of-use asset | 288,000 | 281,000 | 275,000 | 269,000 | 271,000 | 281,000 | 275,000 | 270,000 | 254,000 | 242,000 | 260,000 | 254,000 | 215,000 | 158,000 | 155,000 | 152,000 | 149,000 | 146,000 | 142,000 | 140,000 | 138,000 | 162,000 |
non-cash interest expense | 187,000 | 222,000 | 219,000 | 201,000 | 181,000 | 218,000 | 214,000 | 349,000 | 200,000 | -8,000 | 82,000 | 84,000 | 83,000 | 77,000 | 40,000 | 84,000 | 471,000 | |||||
loss on disposal of property and equipment | 16,000 | 0 | 0 | 144,000 | 5,000 | 0 | 55,000 | 120,000 | 1,000 | 0 | ||||||||||||
benefit from doubtful accounts receivable | ||||||||||||||||||||||
benefit from excess and obsolete inventories | 171,000 | 175,000 | 175,000 | 9,000 | 13,000 | 1,000 | 1,000 | 8,000 | 5,000 | -8,000 | 21,000 | 6,000 | 26,000 | 24,000 | 8,000 | 4,000 | 13,000 | 92,000 | 40,000 | 35,000 | 16,000 | 27,000 |
changes in assets and liabilities: | ||||||||||||||||||||||
accounts receivable | 951,000 | -3,630,000 | -1,794,000 | -279,000 | -1,569,000 | -1,968,000 | -988,000 | -1,240,000 | -1,906,000 | -2,038,000 | -863,000 | 771,000 | -641,000 | -2,036,000 | 334,000 | -1,628,000 | 917,000 | -60,000 | 1,334,000 | -1,953,000 | -1,732,000 | 110,000 |
inventories | 633,000 | -785,000 | -7,985,000 | -3,009,000 | -1,896,000 | 2,109,000 | 999,000 | -2,685,000 | 105,000 | 134,000 | -1,819,000 | -3,288,000 | 1,334,000 | -1,790,000 | -1,429,000 | 672,000 | 467,000 | -1,871,000 | -1,087,000 | -347,000 | -923,000 | -2,339,000 |
prepaid expenses and other current assets | -9,561,000 | 2,369,000 | -1,635,000 | 266,000 | -495,000 | -124,000 | 607,000 | 110,000 | -2,089,000 | 847,000 | 1,242,000 | 1,213,000 | -3,810,000 | 583,000 | 815,000 | 421,000 | -1,969,000 | 983,000 | 625,000 | -255,000 | -1,857,000 | 16,000 |
other assets | -7,000 | 115,000 | 17,000 | -129,000 | -107,000 | -17,000 | 25,000 | -15,000 | -32,000 | -5,000 | -10,000 | -33,000 | -68,000 | -6,000 | 10,000 | 83,000 | 62,000 | 55,000 | -212,000 | 8,000 | 1,407,000 | -651,000 |
accounts payable | 719,000 | -2,937,000 | 586,000 | -258,000 | 67,000 | 2,668,000 | -698,000 | 589,000 | 1,057,000 | 19,000 | -2,463,000 | 2,137,000 | -1,051,000 | 218,000 | 563,000 | -233,000 | -1,012,000 | 1,274,000 | -97,000 | 757,000 | -2,332,000 | 2,287,000 |
accrued liabilities | 9,524,000 | -6,256,000 | 5,662,000 | 169,000 | 3,411,000 | -6,388,000 | 2,612,000 | 1,876,000 | 548,000 | -3,168,000 | 3,789,000 | 1,111,000 | 1,941,000 | -2,423,000 | 2,200,000 | 3,871,000 | -2,013,000 | -3,912,000 | 2,709,000 | 1,878,000 | 325,000 | 52,000 |
other liabilities | -403,000 | -443,000 | -85,000 | -319,000 | -340,000 | -471,000 | -346,000 | -346,000 | -378,000 | 380,000 | -1,176,000 | 989,000 | -328,000 | -5,000 | -150,000 | 183,000 | 196,000 | -203,000 | -200,000 | -197,000 | 697,000 | -1,069,000 |
net cash from operating activities | -3,383,000 | -15,322,000 | -8,453,000 | -6,798,000 | -4,616,000 | -12,147,000 | -2,724,000 | -4,726,000 | -10,406,000 | -14,725,000 | -11,432,000 | -6,495,000 | -9,036,000 | -11,972,000 | -14,269,000 | -4,423,000 | -11,581,000 | -11,795,000 | -5,261,000 | -6,346,000 | -9,383,000 | -8,620,000 |
capital expenditures | -946,000 | -161,000 | -457,000 | -318,000 | -436,000 | -229,000 | -1,626,000 | -318,000 | -1,510,000 | -1,434,000 | -2,912,000 | -117,000 | -630,000 | 39,000 | -10,000 | -90,000 | -267,000 | -112,000 | 23,000 | -129,000 | -15,000 | -95,000 |
free cash flows | -4,329,000 | -15,483,000 | -8,910,000 | -7,116,000 | -5,052,000 | -12,376,000 | -4,350,000 | -5,044,000 | -11,916,000 | -16,159,000 | -14,344,000 | -6,612,000 | -9,666,000 | -11,933,000 | -14,279,000 | -4,513,000 | -11,848,000 | -11,907,000 | -5,238,000 | -6,475,000 | -9,398,000 | -8,715,000 |
cash flows from investing activities | ||||||||||||||||||||||
purchases of property and equipment | -954,000 | -388,000 | -453,000 | -333,000 | -434,000 | -287,000 | -1,567,000 | -389,000 | -977,000 | -2,072,000 | -2,752,000 | -1,132,000 | -807,000 | -67,000 | -108,000 | -345,000 | -134,000 | -131,000 | ||||
purchases of investments | -71,595,000 | -43,871,000 | -26,127,000 | -34,711,000 | -87,724,000 | -26,407,000 | -114,484,000 | -32,506,000 | -21,022,000 | -35,278,000 | -21,632,000 | -1,974,000 | ||||||||||
proceeds from maturity of investments | 62,875,000 | 62,000,000 | 25,000,000 | 42,500,000 | 69,000,000 | 32,800,000 | 17,000,000 | 9,100,000 | 15,000,000 | 36,300,000 | 34,175,000 | 28,000,000 | 7,180,000 | 2,000,000 | ||||||||
net cash from investing activities | -9,674,000 | 17,741,000 | -1,580,000 | 7,456,000 | -19,158,000 | 6,106,000 | -104,951,000 | -32,895,000 | -22,150,000 | -2,072,000 | 14,250,000 | 7,968,000 | 14,193,000 | 36,233,000 | 12,898,000 | -7,386,000 | -14,797,000 | -108,000 | -69,619,000 | -131,000 | -89,000 | -117,000 |
cash flows from financing activities | ||||||||||||||||||||||
proceeds from issuance of common stock | 1,055,000 | 130,000 | 1,592,000 | 1,110,000 | 2,729,000 | 1,338,000 | 1,561,000 | 168,000 | 1,739,000 | 2,242,000 | 2,117,000 | 848,000 | 2,359,000 | 1,130,000 | 1,405,000 | 274,000 | 1,784,000 | 68,000 | 363,000 | 375,000 | ||
net cash from financing activities | 1,055,000 | 130,000 | 1,592,000 | 1,110,000 | 111,727,000 | 1,213,000 | 26,591,000 | 168,000 | 1,771,000 | 2,242,000 | 2,117,000 | 848,000 | 8,369,000 | 835,000 | 72,268,000 | 274,000 | 1,784,000 | 507,000 | 112,210,000 | -744,000 | ||
net change in cash and cash equivalents | ||||||||||||||||||||||
cash and cash equivalents, beginning of period | ||||||||||||||||||||||
cash and cash equivalents, end of period | ||||||||||||||||||||||
supplemental disclosure of cash flow information | ||||||||||||||||||||||
cash paid for interest | 1,479,000 | 1,440,000 | 1,457,000 | 1,472,000 | 1,474,000 | 1,418,000 | 1,460,000 | 1,296,000 | 505,000 | 582,000 | 789,000 | 394,000 | 595,000 | 582,000 | 4,581,000 | 1,120,000 | 1,108,000 | 1,108,000 | 1,127,000 | 1,125,000 | 1,112,000 | 870,000 |
noncash investing and financing activities: | ||||||||||||||||||||||
accounts payable and accrued liabilities for purchases of property and equipment | 8,000 | 227,000 | -4,000 | 15,000 | -2,000 | 58,000 | -59,000 | 71,000 | -533,000 | 638,000 | -160,000 | 1,015,000 | 177,000 | 106,000 | -10,000 | 18,000 | 78,000 | 22,000 | 23,000 | 2,000 | -15,000 | 22,000 |
right-of-use asset obtained in exchange for lease obligation | 0 | 0 | 0 | 0 | -91,000 | 0 | 0 | 0 | 0 | 3,982,000 | ||||||||||||
net change in cash, cash equivalents and restricted cash | 2,419,000 | -8,978,000 | 788,000 | -22,182,000 | -4,931,000 | 4,052,000 | -36,408,000 | -5,965,000 | -16,629,000 | 4,589,000 | 3,715,000 | 7,274,000 | 25,109,000 | 6,998,000 | -10,974,000 | 45,890,000 | -11,629,000 | -73,096,000 | -5,970,000 | 102,738,000 | -9,481,000 | |
cash, cash equivalents and restricted cash, beginning of period | 20,210,000 | 0 | 0 | 55,513,000 | 0 | 0 | 110,463,000 | 0 | 0 | 69,776,000 | 0 | 0 | 39,491,000 | 0 | 0 | 25,300,000 | ||||||
cash, cash equivalents and restricted cash, end of period | 22,629,000 | 788,000 | -22,182,000 | 50,582,000 | -36,408,000 | -5,965,000 | 93,834,000 | 3,715,000 | 7,274,000 | 94,885,000 | -10,974,000 | 45,890,000 | 27,862,000 | -5,970,000 | 102,738,000 | 15,819,000 | ||||||
amortization of premiums (accretion of discounts) on investments | -1,753,000 | -1,081,000 | -274,000 | 159,000 | 88,000 | |||||||||||||||||
loss on extinguishment of debt | 0 | 0 | ||||||||||||||||||||
benefit from (recovery of) doubtful accounts receivable | ||||||||||||||||||||||
changes in operating assets and liabilities: | ||||||||||||||||||||||
proceeds from sale of property and equipment | ||||||||||||||||||||||
proceeds from public offerings, net of underwriting discount, commissions and offering costs paid | 0 | -295,000 | ||||||||||||||||||||
proceeds from long-term debt | -1,089,000 | 0 | ||||||||||||||||||||
principal repayment of long-term debt | ||||||||||||||||||||||
proceeds from disgorgement of short-swing profits | ||||||||||||||||||||||
cash, cash equivalents and restricted cash, beginning of year | ||||||||||||||||||||||
cash, cash equivalents and restricted cash, end of year | ||||||||||||||||||||||
change in accounts receivable allowances | 26,000 | 0 | 19,000 | |||||||||||||||||||
principal repayment of debt | 0 | |||||||||||||||||||||
payments of debt issuance costs | -116,000 | |||||||||||||||||||||
payments of deferred offering costs | -1,149,000 | |||||||||||||||||||||
unpaid debt issuance costs | -116,000 | |||||||||||||||||||||
unpaid deferred offering costs | 1,204,000 | |||||||||||||||||||||
change in benefit from doubtful accounts receivable | 0 | 0 | 3,000 | -6,000 | -6,000 | -17,000 | 0 | -9,000 | ||||||||||||||
repayment of interest paid in kind | ||||||||||||||||||||||
payments of prepayment penalty and lender fees | ||||||||||||||||||||||
amortization of premiums on investments | 64,000 | 201,000 | 186,000 | |||||||||||||||||||
change in fair value of redeemable convertible preferred stock warrant liability | 0 | 0 | 5,318,000 | 15,712,000 | ||||||||||||||||||
proceeds from exercise of redeemable convertible preferred stock warrants | 0 | 0 | ||||||||||||||||||||
proceeds from exercise of common stock warrants | 0 | 0 | ||||||||||||||||||||
net exercise of convertible preferred stock warrants to preferred stock | 0 | |||||||||||||||||||||
conversion of convertible preferred stock to common stock upon initial public offering | 0 | |||||||||||||||||||||
offering costs in accrued liabilities | ||||||||||||||||||||||
changes in assets and liabilities | ||||||||||||||||||||||
purchase of property and equipment | -117,000 | |||||||||||||||||||||
non-controlling interest | ||||||||||||||||||||||
non-cash investing and financing activities: | ||||||||||||||||||||||
landlord paid tenant improvements | ||||||||||||||||||||||
net exercise of redeemable convertible preferred stock warrants to preferred stock | ||||||||||||||||||||||
conversion of redeemable convertible preferred stock to common stock upon initial public offering | ||||||||||||||||||||||
offering costs in accounts payable and accrued liabilities | -295,000 | |||||||||||||||||||||
amortization of premium on investments | 79,000 | |||||||||||||||||||||
payment of deferred offering costs | ||||||||||||||||||||||
accretion of discount on investments | ||||||||||||||||||||||
proceeds from initial public offering, net of underwriting discount, commissions and offering costs paid | 0 | 439,000 | ||||||||||||||||||||
benefit from sales returns and allowances | ||||||||||||||||||||||
benefit from accounts receivable allowances | 411,000 | 313,000 | ||||||||||||||||||||
proceeds from exercise of preferred stock warrants | 30,000 |